Ask AI
ProCE Banner Activity

Antiretroviral Pregnancy Registry Analysis of Pregnancy and Neonatal Outcomes Following Prenatal Cabotegravir Exposure 

Conference Coverage
Slideset

Results from an analysis of pregnancy and neonatal outcomes from individuals exposed to cabotegravir preconception and reported to the Antiretroviral Pregnancy Registry (APR) showed a positive safety profile among a limited number of pregnancies.

Released: July 18, 2025

Expiration: January 17, 2026

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC in partnership with the International AIDS Society

 
ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Partners

IAS

ProCE Banner